Search This Blog

Thursday, February 13, 2020

West Pharmaceutical EPS beats by $0.10, beats on revenue

West Pharmaceutical (NYSE:WST): Q4 Non-GAAP EPS of $0.82 beats by $0.10; GAAP EPS of $0.84 beats by $0.14.
Revenue of $470.6M (+11.4% Y/Y) beats by $19.07M.
Press Release
https://wordpress.com/post/awesomecapital.wordpress.com/110041
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)